Researchers: Improving Eyesight May Help Prevent Dementia
As experimental drugs prove ineffective against increasing dementia cases in the U.S., researchers argue that improving eyesight can have an effect.
As experimental drugs prove ineffective against increasing dementia cases in the U.S., researchers argue that improving eyesight can have an effect.
Low-income Americans on Medicare can get assistance paying their premiums and other expenses. Several states have allowed more people to qualify.
Studies linked to Cassava Sciences, once a stock market favorite, have been retracted or challenged by medical journals.
The Alzheimer’s Association has pushed relentlessly to get broad access to Aduhelm, despite safety risks and uncertain evidence that it helps patients.
Financial planning for people with chronic diseases is complicated and multifaceted. Start by building a team of people to help.
Financial planning for people with chronic diseases is complicated and multifaceted. Start by building a team of people to help.
Financial planning for people with chronic diseases is complicated and multifaceted. Start by building a team of people to help.
If the preliminary decision is finalized this spring, it would restrict coverage to patients in randomized clinical trials.
If the preliminary decision is finalized this spring, it would restrict coverage to patients in randomized clinical trials.
If the preliminary decision is finalized this spring, it would sharply limit the number of patients who use the expensive drug.
Medicare officials are trying to determine whether to cover Aduhelm, which the F.D.A. approved despite unclear evidence that it helps patients.
A higher Medicare premium in 2022 is just part of the puzzle of health care costs for older Americans. But there are ways to plan.
A higher Medicare premium in 2022 is just part of the puzzle of health care costs for older Americans. But there are ways to plan.
A higher Medicare premium in 2022 is just part of the puzzle of health care costs for older Americans. But there are ways to plan.
A higher Medicare premium in 2022 is just part of the puzzle of health care costs for older Americans. But there are ways to plan.
A higher Medicare premium in 2022 is just part of the puzzle of health care costs for older Americans. But there are ways to plan.
Newly published safety data shows that 41 percent of patients in key clinical trials of the Alzheimer’s drug experienced brain bleeding or swelling, though many […]
Newly published safety data shows that 41 percent of patients in key clinical trials of the Alzheimer’s drug experienced brain bleeding or swelling, though many […]
Newly published safety data shows that 41 percent of patients in key clinical trials of the Alzheimer’s drug experienced brain bleeding or swelling, though many […]
Newly published safety data shows that 41 percent of patients in key clinical trials of the Alzheimer’s drug experienced brain bleeding or swelling, though many […]
Newly published safety data shows that 41 percent of patients in key clinical trials of the Alzheimer’s drug experienced brain bleeding or swelling, though many […]
Newly published safety data shows that 41 percent of patients in key clinical trials of the Alzheimer’s drug experienced brain bleeding or swelling, though many […]
With prices rising at their fastest rate in decades, people in retirement or approaching it should take extra care to protect their savings.
With prices rising at their fastest rate in decades, people in retirement or approaching it should take extra care to protect their savings.
With prices rising at their fastest rate in decades, people in retirement or approaching it should take extra care to protect their savings.
With prices rising at their fastest rate in decades, people in retirement or approaching it should take extra care to protect their savings.
The provision would, for the first time, allow the government to negotiate prices for some medicines covered by Medicare.
The provision would, for the first time, allow the government to negotiate prices for some medicines covered by Medicare.
Most Medicare beneficiaries don’t compare plans during open enrollment season, and may be paying more, or accepting more restrictions, than they should.
Most Medicare beneficiaries don’t compare plans during open enrollment season, and may be paying more, or accepting more restrictions, than they should.
Too often, seniors who use opioids become targets for exploitation and abuse.
Too often, seniors who use opioids become targets for exploitation and abuse.
Too often, seniors who use opioids become targets for exploitation and abuse.
Too often, seniors who use opioids become targets for exploitation and abuse.
Independent experts, including government scientists, were skeptical of the research from Israel, which included limited data over a short period.
Too often, seniors who use opioids become targets for exploitation and abuse.
Independent experts, including government scientists, were skeptical of the research from Israel, which included limited data over a short period.
Independent experts, including government scientists, were skeptical of the research from Israel, which included limited data over a short period.
At least 21 percent of nursing home residents are on antipsychotic drugs, a Times investigation found.
For an increasingly important set of drugs, Medicare has been driving up prices. It knows how to do better.
For an increasingly important set of drugs, Medicare has been driving up prices. It knows how to do better.
Though some of its own senior officials said there was little evidence of benefit for patients, the F.D.A. nonetheless greenlighted Biogen’s Aduhelm, or aducanumab.
The major medical center’s rejection of the new Alzheimer’s drug is one of the starkest signs of concern over its effectiveness.
The approval of Aduhelm to treat Alzheimer’s disease has raised hope among older adults, but many doctors wonder if it is warranted.
The approval of Aduhelm to treat Alzheimer’s disease has raised hope among older adults, but many doctors wonder if it is warranted.
The drug, Aduhelm, a monthly infusion priced at $56,000 per year, was approved this week despite weak evidence that it helps patients.
The drug, Aduhelm, a monthly infusion priced at $56,000 per year, was approved this week despite weak evidence that it helps patients.
Older adults often take more medications than they need, or than is safe. Increasingly, geriatric experts and their patients are exploring the benefits of “deprescribing.”
Older adults often take more medications than they need, or than is safe. Increasingly, geriatric experts and their patients are exploring the benefits of “deprescribing.”
If the agency approves it, aducanumab would be the first new Alzheimer’s treatment since 2003. Patients are desperate for new options, but some scientists say […]
If the agency approves it, aducanumab would be the first new Alzheimer’s treatment since 2003. Patients are desperate for new options, but some scientists say […]
Over 150 House Democrats are pushing the president to include a plan in his infrastructure package to lower the eligibility age, expand benefits and negotiate […]
Over 150 House Democrats are pushing the president to include a plan in his infrastructure package to lower the eligibility age, expand benefits and negotiate […]
Bureaucratic inertia, a diffusion of responsibility and logistical problems have seriously undercut vaccination efforts. In Italy, it’s the older population that bears the brunt.
Bureaucratic inertia, a diffusion of responsibility and logistical problems have seriously undercut vaccination efforts. In Italy, it’s the older population that bears the brunt.
Bureaucratic inertia, a diffusion of responsibility and logistical problems have seriously undercut vaccination efforts. In Italy, it’s the older population that bears the brunt.
A monoclonal antibody protected residents and staff members in facilities where the virus had appeared.
A monoclonal antibody protected residents and staff members in facilities where the virus had appeared.
A monoclonal antibody protected residents and staff members in facilities where the virus had appeared.
A monoclonal antibody protected residents and staff members in facilities where the virus had appeared.
A monoclonal antibody protected residents and staff members in facilities where the virus had appeared.
A monoclonal antibody protected residents and staff members in facilities where the virus had appeared.
Even as older adults await the coronavirus vaccine, many are skipping the standard ones. That’s not wise, health experts say.
Even as older adults await the coronavirus vaccine, many are skipping the standard ones. That’s not wise, health experts say.
The three-month pilot program involves just 1,000 doses of the medication in seven big cities. It’s not clear how much impact that will have as […]
Un panel asesor de los CDC decidirá sus recomendaciones el martes por la tarde. Esto es lo que esperamos, junto con las respuestas a otras […]
A C.D.C. advisory panel will decide on its recommendations on Tuesday afternoon. Here’s what we expect, along with answers to other questions about the new […]
Science and objective analysis need to be revived.
Having hypertension in midlife (ages 40 through 60) is associated with elevated risk of cognitive impairment and Alzheimer’s dementia later in life, even more so […]
Eating seaweed salad may boost the efficacy of vaccinations and help treat cold sores, herpes, Epstein-Barr virus, and shingles. Billions of pounds of seaweed are […]
Unlike most antiviral drugs, green tea appears to work by boosting the immune system to combat diseases such as genital warts (caused by HPV) and […]
We have known for more than 400 years that muscle weakness is a common presenting symptom of vitamin D deficiency. Bones aren’t the only organs […]
The post COVID-19 visitor restrictions are isolating seniors appeared first on Healthy Debate.
Copyright © 2024 | WordPress Theme by MH Themes